Artículos por temáticas

Fyn Kinase in Alzheimer's Disease: Unraveling Molecular Mechanisms and Therapeutic Implications

Meur S, Karati D.

Mol Neurobiol. 2025 Jan;62(1):643-660. doi: 10.1007/s12035-024-04286-2. Epub 2024 Jun 18.

Exploring DPP IV inhibitors for Alzheimer's disease: Bridging diabetes and neurodegeneration

Pattanaik S, Prusty SK, Sahu PK.

Brain Res. 2025 Feb 1;1848:149342. doi: 10.1016/j.brainres.2024.149342. Epub 2024 Nov 19.

Flavonoids and Alzheimer's disease: reviewing the evidence for neuroprotective potential

Al Amin M, Dehbia Z, Nafady MH, Zehravi M, Kumar KP, Haque MA, Baig MS, Farhana A, Khan SL, Afroz T, Koula D, Tutone M, Nainu F, Ahmad I, Emran TB.

Mol Cell Biochem. 2025 Jan;480(1):43-73. doi: 10.1007/s11010-023-04922-w. Epub 2024 Apr 3.

Novel techniques for early diagnosis and monitoring of Alzheimer's disease

Parul, Singh A, Shukla S.

Expert Rev Neurother. 2025 Jan;25(1):29-42. doi: 10.1080/14737175.2024.2415985. Epub 2024 Oct 22.

The LDL Receptor-Related Protein 1: Mechanisms and roles in promoting Aβ efflux transporter in Alzheimer's disease

Li W, Chen C, Xu B, Chen J, Yang M, Gao L, Zhou J.

Biochem Pharmacol. 2025 Jan;231:116643. doi: 10.1016/j.bcp.2024.116643. Epub 2024 Nov 20.

Comparison of the efficacy of updated drugs for the treatment on the improvement of cognitive function in patients with Alzheimer 's disease: A systematic review and network meta- analysis

Cao W, Zhu B, Liu Z, Jia X, Zhao H, Gu N, Chang H, Xi J, Li R, Guo K, Shen J, Ding L, Sun F, Di Z.

Neuroscience. 2025 Jan 26;565:29-39. doi: 10.1016/j.neuroscience.2024.11.029. Epub 2024 Nov 15.

Efficacy and molecular mechanisms of hesperidin in mitigating Alzheimer's disease: A systematic review

Han X, Zhang Y, Zhang L, Zhuang Y, Wang Y.

Eur J Med Chem. 2025 Feb 5;283:117144. doi: 10.1016/j.ejmech.2024.117144. Epub 2024 Dec 4.

Advances in Alzheimer's disease control approaches via carbon nanotubes

Cai J, Li B, Zhang J, Feng G, Liu Y, Fan H, Zheng B.

Nanomedicine (Lond). 2025 Jan;20(1):63-77. doi: 10.1080/17435889.2024.2432855. Epub 2024 Nov 28.

The Neuroprotective Effect of Rooibos Herbal Tea Against Alzheimer's Disease: A Review

Chipofya E, Docrat TF, Marnewick JL.

Mol Nutr Food Res. 2025 Jan;69(1):e202400670. doi: 10.1002/mnfr.202400670. Epub 2024 Dec 19.

The Role of Gut Microbiota in the Neuroprotective Effects of Selenium in Alzheimer's Disease

Skalny AV, Aschner M, Santamaria A, Filippini T, Gritsenko VA, Tizabi Y, Zhang F, Guo X, Rocha JBT, Tinkov AA.

Mol Neurobiol. 2025 Feb;62(2):1675-1692. doi: 10.1007/s12035-024-04343-w. Epub 2024 Jul 16.

Phase 2A Proof-of-Concept Double-Blind, Randomized, Placebo-Controlled Trial of Nicotinamide in Early Alzheimer Disease

Grill JD, Tam S, Thai G, Vides B, Pierce AL, Green K, Gillen DL, Teng E, Kremen S, Beigi M, Rissman RA, Léger GC, Balasubramanian A, Revta C, Morrison R, Jennings R, Pa J, Zhang J, Jin S, Messer K, Fe

Neurology. 2025 Jan 14;104(1):e210152. doi: 10.1212/WNL.0000000000210152. Epub 2024 Dec 13.

Heavy metals exposure and Alzheimer's disease: Underlying mechanisms and advancing therapeutic approaches

Althobaiti NA.

Behav Brain Res. 2025 Jan 5;476:115212. doi: 10.1016/j.bbr.2024.115212. Epub 2024 Aug 24.

Alzheimer's Disease Clinical Trials: What Have We Learned From Magnetic Resonance Imaging

By S, Kahl A, Cogswell PM.

J Magn Reson Imaging. 2025 Feb;61(2):579-594. doi: 10.1002/jmri.29462. Epub 2024 Jun 20.

Unveiling tomorrow: Carbonic anhydrase activators and inhibitors pioneering new frontiers in Alzheimer's disease

Mishra KA, Sethi KK.

Arch Pharm (Weinheim). 2025 Jan;358(1):e2400748. doi: 10.1002/ardp.202400748. Epub 2024 Nov 6.

Melatonin: A potential nighttime guardian against Alzheimer's

Zhang Z, Xue P, Bendlin BB, Zetterberg H, De Felice F, Tan X, Benedict C.

Mol Psychiatry. 2025 Jan;30(1):237-250. doi: 10.1038/s41380-024-02691-6. Epub 2024 Aug 11.